Gsk (GSK) Other Operating Expenses (2009 - 2026)

Gsk's Other Operating Expenses history runs 18 years deep, the most recent figure standing at -$265.7 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 265.94% year-over-year to -$265.7 million; the TTM figure through Jun 2026 stood at -$179.9 million (up 92.01% YoY), while the FY2025 annual figure was $21.1 million, up 101.08% from the prior year.
• Other Operating Expenses for Q2 2026 stood at -$265.7 million, down from $209.0 million in the prior quarter.
• The five-year high for Other Operating Expenses was $890.3 million in Q4 2022, with the low at -$2.0 billion in Q4 2024.
• The 5-year median for Other Operating Expenses is -$84.7 million (2025), against an average of -$154.4 million.
• The sharpest annual moves came in 2022 and 2026: Other Operating Expenses tumbled 520.01% in 2022, then soared 1608.3% in 2026.
• Gsk's Other Operating Expenses stood at $890.3 million in 2022, then decreased by 19.84% to $713.7 million in 2023, then slumped by 375.17% to -$2.0 billion in 2024, then jumped by 92.07% to -$155.6 million in 2025, then sank by 70.7% to -$265.7 million in 2026.
• Business Quant data shows GSK's Other Operating Expenses at -$265.7 million in Q2 2026, $209.0 million in Q1 2026, and -$155.6 million in Q4 2025.